Organizational and managementimpact analysis of using the new subcutaneous formulation of tocilizumab in selected italian rheumatology centers.
Organizational and Management Impact Analysis of Using the New Subcutaneous Formulation of Tocilizumab in Selected Italian Rheumatology Centers
Adami, S;Viapiana, O;Farina, Maria Luisa;Ciancio, G;
2014-01-01
Abstract
Organizational and managementimpact analysis of using the new subcutaneous formulation of tocilizumab in selected italian rheumatology centers.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
